Author Archives: Elmar Scheuba

Elmar Scheuba

About Elmar Scheuba

Elmar Scheuba disposes of more than 19 years' of professional work experience with deep functional knowledge of International Medical Devices, Pharmaceutical, Biotech and Health Care markets in general, and had the opportunity to gain substantial financial Health Care experience as a global buy side-equity analyst for an exclusive Health Care investment-boutique in Basel/Switzerland, where he could successfully sign responsible for worldwide Medical Services Research (Hospitals, Distributors, HMO's, Health Care IT). During his several professional assignments he also gained valuable experience in the Endovascular Medical Devices industry at Medtronic Corporation and got an extensive insight in Novartis‘ Pharmaceutical Drug Regulatory Affairs (DRA) business. In addition, he was later performing as an International Product Manager for Lohmann & Rauscher International, a leading European supplier of bandaging material and medical products and could further contribute to Deloitte’s Life Science consulting business in Zurich/Switzerland. Elmar Scheuba is now - very successfully - working at RSA Consulting. RSA is a global leader in the provision of Executive Search and Interim Management to the life sciences industries. With offices in the UK – the head office in Hertfordshire and premises in London - plus China, Germany, Singapore, Switzerland and the USA, RSA consultants talk to hundreds of industry leaders every day, and the RSA network reaches every corner of the worldwide pharmaceutical, biotechnology and allied industries. Elmar Scheuba is a Health Economist and graduate of "Health Care Management" master studies at International Management Center Krems (IMC)/Austria with the focus on International pharmaceutical management, International hospital management and International Health Care Consulting. He is located in Austria, is married and fluently speaks German, English and Spanish language.

What are the key trends in global mHealth industry and which of its segments will be the key growth drivers over the next 12 months?

  1. Monitoring services (up to 66% of the Global mHealth market share)
  • Remote Patient monitoring
      • (e.g. Obesity Management
      • Healthy Living
      • Pregnancy Tips
      • Elderly Care
      • Smoking De-addiction
      • Infectious Diseases
      • Reproductive Health
      • Child Health / Child Care…)
  • Video conferencing and online consultations
          • e.g. Telephone-based consultations
          • Video consultations
          • Text-based consultations…
  • Personal healthcare devices
  • Wireless access to patient records and prescriptions
  • Chronic disease managementIndependent ageing applications in developed markets 
  • Post acute care monitoring services
  • Monitoring of patients with metabolic conditions such as obesity and Diabetes (is expected to comprise about 40% of the chronic disease management Segment)
  • Monitoring patients with cardiovascular conditions such as hypertension, coronary artery disease and congestive heart failure (is expected to contribute about 45% to chronic disease management revenues in the US and about 80% in China).
  • Analysis of general health and wellness data gathered by mobile devices

 2. Diagnostic Services (up to 16% of the Global mHealth market share)

  • Interactive messages that help patients self-diagnose minor ailments
  • Medical call centres / help-lines manned by healthcare professionals
  • Telemedicine solutions that enable doctors to ‘see’ patients through wireless broadband
  • A majority of the revenues from Diagnosis services are expected to come from call-centre and mobile telemedicine solutions.              
  • The adoption of Diagnosis services is expected to support developing markets in bridging their healthcare access challenges.

 3. Treatment Services (up to 11% of the Global mHealth market share)

  • Emergency Response
  • Ambulance based Solutions
  • Treatment Compliance
  • Appointment Reminders
  • Use of mobile device to explain/demonstrate during office visits
  • Provide patients access to portions of their medical record
  • Drug adherence and other health-related communication

 4. Healthcare System strengthening Services (up to 7% of the Global mHealth market share)

  • Patient-centred care
  • Wellness (up to 3% of the Global mHealth market share)
  • Prevention (up to 1% of the Global mHealth market share)
      • e.g. Drug Abuse Prevention
  • Information Lookup and Decision Support
  • Health Surveys & Healthcare Surveillance
  • Healthcare Practitioner Support
  • Healthcare Administration& administrative communication